Long non-coding RNA NPPA-AS1 acts as a potential novel biomarker and promotes atrial fibrillation progression via the miR-302e/TGFBR2 axis

Journal of Thrombosis and Thrombolysis · Published 2026-06-10 · DOI 10.1007/s11239-026-03327-y

Authors (5)

Sheng Li, Nina Chen, Qingli Wang, Bo Li, Youlin Fu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, S., Chen, N., Wang, Q., et al. (2026). Long non-coding RNA NPPA-AS1 acts as a potential novel biomarker and promotes atrial fibrillation progression via the miR-302e/TGFBR2 axis. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03327-y

Related articles

• The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19 · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Systemic immune-inflammation index predicts left atrial thrombus in non-valvular atrial fibrillation: A retrospective study of 847 patients · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• A qualitative study of warfarin self-management in the United States healthcare system: insights from patient experiences · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Localized antithrombotic but minimal systemic coagulation effects of sodium bicarbonate in mechanical circulatory support · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Practice patterns of DOAC high-intensity period following parenteral lead-in treatment for venous thromboembolism · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Verification and optimization of the VTE risk stratification system for multiple myeloma · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Antiplatelet effects of oral anticoagulants in patients with atrial fibrillation: ex-vivo studies · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Extended anticoagulation with DOACs in patients affected by hematologic malignancies and venous thromboembolism: a monocentric experience · Journal of Thrombosis and Thrombolysis · 2026 · Same journal